Dyne Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	753.1	893.37	435.45	121.63	172.15	200.83
Short-Term Investments	219.05	217.19	206.82	1.47	83.87	175.75
Cash & Short-Term Investments	972.16	1,111	642.27	123.1	256.01	376.57
Cash Growth	43.49%	72.91%	421.75%	-51.92%	-32.02%	9.05%
Other Current Assets	48.87	16.03	17.01	6.28	9.58	5.82
Total Current Assets	1,021	1,127	659.28	129.38	265.59	382.39
Net Property, Plant & Equipment	43.33	44.77	30.01	33.39	38.41	40.96
Other Long-Term Assets	15.59	15.6	1.94	2.32	2.32	2.31
Total Assets	1,080	1,187	691.23	165.08	306.33	425.66
Accounts Payable	10.78	8.08	6.56	22.94	5.26	4.03
Accrued Expenses	29.21	37.55	30.85	23.44	18.22	20.8
Current Portion of Leases	5.03	5	4.85	4.72	4.61	3.89
Other Current Liabilities	6.22	-	-	-	-	-
Total Current Liabilities	51.25	50.63	42.26	51.1	28.09	28.72
Long-Term Debt	149.38	148.92	-	-	-	-
Long-Term Leases	14.27	15.28	19.14	22.7	25.87	28.74
Total Long-Term Liabilities	163.65	164.2	19.14	22.7	25.87	28.74
Total Liabilities	214.9	214.83	61.4	73.79	53.96	57.47
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	2,382	2,368	1,580	723.8	649.5	596.93
Accumulated Other Comprehensive Income	-0.14	0.48	0.01	-	-0.57	-0.27
Retained Earnings	-1,517	-1,396	-949.93	-632.51	-396.57	-228.47
Shareholders' Equity	865.06	972.13	629.84	91.29	252.36	368.2
Total Liabilities & Equity	1,080	1,187	691.23	165.08	306.33	425.66
Total Debt	168.68	169.2	23.99	27.42	30.48	32.64
Net Cash (Debt)	803.48	941.36	618.28	95.69	225.53	343.94
Net Cash Growth	-14.65%	52.25%	546.16%	-57.57%	-34.43%	-0.40%
Net Cash Per Share	5.66	7.33	6.57	1.60	4.34	6.76
Book Value	865.06	972.13	629.84	91.29	252.36	368.2
Book Value Per Share	6.09	7.57	6.69	1.53	4.86	7.23
Tangible Book Value	865.06	972.13	629.84	91.29	252.36	368.2
Tangible Book Value Per Share	6.09	7.57	6.69	1.53	4.86	7.23

SEC Filings: 10-K · 10-Q